The antiserum was produced against synthesized peptide derived from human Breast Tumor Kinase around the phosphorylation site of Tyr447. AA range:402-451

Phospho-Brk (Y447) Polyclonal Antibody detects endogenous levels of Brk protein only when phosphorylated at Y447.The name of modified sites may be influenced by many factors, such as species (the modified site was not originally found in human samples) and the change of protein sequence (the previous protein sequence is incomplete, and the protein sequence may be prolonged with the development of protein sequencing technology). When naming, we will use the "numbers" in historical reference to keep the sites consistent with the reports. The antibody binds to the following modification sequence (lowercase letters are modification sites):TSyEN

PTK6

Protein-tyrosine kinase 6

PTK6 ;
BRK ;
Protein-tyrosine kinase 6 ;
Breast tumor kinase ;
Tyrosine-protein kinase BRK

protein tyrosine kinase 6 (PTK6) Homo sapiens The protein encoded by this gene is a cytoplasmic nonreceptor protein kinase which may function as an intracellular signal transducer in epithelial tissues. Overexpression of this gene in mammary epithelial cells leads to sensitization of the cells to epidermal growth factor and results in a partially transformed phenotype. Expression of this gene has been detected at low levels in some breast tumors but not in normal breast tissue. The encoded protein has been shown to undergo autophosphorylation. Alternative splicing results in multiple transcript variants. [provided by RefSeq , Jan 2012] ,

Catalytic activity:ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate. ,enzyme regulation:Activated enzyme seems to have greater access to its substrates. ,Function:Phosphorylates KHDRBS1 , KHDRBS2 , KHDRBS3 and STAP2/BKS. May function as an intracellular signal transducer in epithelial tissues. Overexpression in mammary cells leads to mitogenically sensitization to EGF , and results in a partially transformed phenotype. Its presence in the nucleus appears to be linked to suppression of tumor progression. ,PTM:Autophosphorylated. The phosphorylation of Tyr-447 may lead to the autoinhibition of the enzyme. ,similarity:Belongs to the protein kinase superfamily. Tyr protein kinase family. BRK/PTK6/SIK subfamily. ,similarity:Contains 1 protein kinase domain. ,similarity:Contains 1 SH2 domain. ,similarity:Contains 1 SH3 domain. ,subcellular location:Colocalizes with KHDRBS1 , KHDRBS2 or KHDRBS3 , within the nucleus. In secretory epithelial cells from prostate adenocarcinoma , nuclear localization is higher in low-grade and lower in high-grade regions of the tumors. ,subunit:Interacts with GAP-A.p65 (By similarity) . Interacts with KHDRBS1. Interacts with phosphorylated IRS4. ,tissue specificity:Epithelia-specific. Very high level in colon and high levels in small intestine and prostate , and low levels in some fetal tissues. Expressed at low level in some breast tumors , but not in normal breast. Also found in melanocytes. Not expressed in heart , brain , placenta , lung , liver , skeletal muscle , kidney and pancreas. ,

Cytoplasm. Nucleus. Cell projection , ruffle. Membrane . Colocalizes with KHDRBS1 , KHDRBS2 or KHDRBS3 , within the nucleus. Nuclear localization in epithelial cells of normal prostate but cytoplasmic localization in cancer prostate.